STAGEONE PLUS Trademark

Trademark Overview

On Tuesday, July 22, 2025, a trademark application was filed for STAGEONE PLUS with the United States Patent and Trademark Office. The USPTO has given the STAGEONE PLUS trademark a serial number of 99296669. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 22, 2025. This trademark is owned by Calviri, Inc.. The STAGEONE PLUS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories
stageone plus

General Information

Serial Number99296669
Word MarkSTAGEONE PLUS
Filing DateTuesday, July 22, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBlood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 22, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCalviri, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhoenix, AZ 85004

Trademark Events

Event DateEvent Description
Tuesday, July 22, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, July 22, 2025NEW APPLICATION ENTERED

Related Keywords

plus stageone services medical analysis provided laboratories purposes diagnostic being blood treatment